Incretins and pancreatitis--what happens next? A personal viewpoint.
Centre for Primary Care and Public Health, Queen Mary University of London, London, UK. j.robson@qmul.ac.uk.
J
J
Robson
D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D006801:Humans; D054795:Incretins / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced*; D018570:Risk Assessment; D012307:Risk Factors
D054795:Incretins